Veniti has announced that patients in the EU were successfully treated for symptomatic venous outflow obstruction of the lower extremities with the Veniti Vici venous stent system. These procedures mark the first uses in patients of this ...
Tags: Leipzig, LINC, stent system, demonstration
US-based Boston Scientific has obtained an approval from the US Food and Drug Administration (FDA) for its Promus PREMIER everolimus-eluting platinum chromium coronary stent system. The company's next-generation durable polymer ...
Germany-based biomedical technology company Biotronik has obtained CE Mark approval for its PK Papyrus covered coronary stent system for use in the treatment of acute coronary artery perforation. According to Biotronik, the company's PK ...
Tags: Coronary Stent System, Medicine
US-based Boston Scientific has completed the patient enrolment in the EVOLVE II clinical trial, designed to assess the safety and effectiveness of SYNERGY stent system and support the US Food and Drug Administration and Japanese regulatory ...
Tags: Clinical Trial, Medicine
Abbott has completed its acquisition of Idev Technologies, a privately held firm that manufactures next-generation medical devices for use by interventional radiologists, vascular surgeons and cardiologists, for $310m. Abbott believes ...
Tags: Abbott, Idev Technologies
US-based Abbott has agreed to buy a stent maker and an eye surgery systems manufacturer in two separate deals, worth about $710m, as part of its strategy to expand its medical device business. Illinois-based Abbott agreed to purchase ...
Tags: Stent Maker, Ophthalmic Device
Micell, a US-based biomedical company, has received CE (Conformité Européenne) Mark clearance for its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES). MiStent Sirolimus Eluting Absorbable ...
Tags: Micell, Mistent SES
US-based medical devices developer Elixir Medical has announced that the results of its CE Mark-approved DESyne BD Novolimus Eluting Coronary Stent System with biodegradable polymer coating were outstanding. Its CE Mark-approved DESyne BD ...
InspireMD has received approval for its investigational device exemption (IDE) application from the US Food and Drug Administration (FDA) to initiate MASTER II clinical study of its MGuard embolic protection stent (EPS). The CE-marked ...
Tags: InspireMD, Protection Stent Study
Covidien has completed patient enrollment in its VISIBILITY and DURABILITY Iliac stent clinical study series. The prospective, multinational, multicenter studies, which have enrolled 150 patients from 23 centers in the US and Europe, are ...
US-based medical technology provider Boston Scientific said it is launching the new polymer-based drug-eluting stent (DES) system in the European market as the product has obtained CE mark approval. The Promus Premier everolimus-eluting ...
Abbott has obtained regulatory approval for its XIENCE Xpedition Everolimus Eluting Coronary Stent system,designed for improving coronary artery luminal diameter in patients with symptomatic heart disease due to de novo native coronary ...
Tags: Abbott, FDA, Drug Eluting System, XIENCE, symptomatic heart disease
Svelte Medical Systems has treated the first patient in the ACES (Acrobat Coronary stent system effectiveness European Study) clinical trial. ACES is a randomized, controlled study to show the clinical benefit and utilization of the ...
Tags: Svelte Medical Systems, clinical trial, ACES, company news
Flexible Stenting Solutions (FSS) has received CE Mark for 6 Fr Reconstrainable FlexStent self-expanding stent system and will now be able to market the stent delivery technology in the European Union. The new device, which integrates the ...
Tags: Flexible Stenting Solutions, stent system, stent delivery technology
Svelte Medical Systems has treated the first patient in a randomized, controlled study using its fixed-wire based system, designed for treating patients with coronary artery lesions. The low profile Svelte Acrobat Integrated Delivery ...
Tags: Svelte Medical Systems, fixed wire based system, coronary artery lesions